Elizabeth M. Jaffee
Pancreatic cancer immunologist who developed the GVAX vaccine and led national cancer policy panels.
Developed GVAX-pancreas and studies of converting immunologically cold pancreatic tumours; former AACR president and chair of the NCI's National Cancer Advisory Board.
| Title | Journal | Year |
|---|---|---|
| Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation | Cancer Immunology Research | 2014 |
Pages like this
not linked directly; found by shared links- PersonKellie N. Smith
Shares Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center, Immune checkpoint inhibitors.
- TrialAMPLIFY-7P
Shares Off-the-shelf cancer vaccines, Pancreatic ductal adenocarcinoma.
- PersonJames L. Gulley
Shares Off-the-shelf cancer vaccines, Immune checkpoint inhibitors.
- IdeaAI that spots pancreatic cancer on scans taken a year before diagnosis
Shares Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center, Pancreatic ductal adenocarcinoma.
- PersonDung T. Le
Shares Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center, Pancreatic ductal adenocarcinoma.
- PersonSuzanne L. Topalian
Shares Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center, Immune checkpoint inhibitors.
- IdeaOff-the-shelf KRAS vaccines after pancreatic cancer surgery
Shares Off-the-shelf cancer vaccines, Pancreatic ductal adenocarcinoma.
- PersonDrew M. Pardoll
Shares Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center, Immune checkpoint inhibitors.